Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Safety and tolerability of antipsychotic polypharmacy.

Gallego JA, Nielsen J, De Hert M, Kane JM, Correll CU.

Expert Opin Drug Saf. 2012 Jul;11(4):527-42. doi: 10.1517/14740338.2012.683523. Epub 2012 May 8.

2.

[Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].

Haefliger T, Bonsack C.

Encephale. 2006 Jan-Feb;32(1 Pt 1):97-105. French.

PMID:
16633296
3.

Paediatric atypical antipsychotic monitoring safety (PAMS) study: pilot study in children and adolescents in secondary- and tertiary-care settings.

Rani FA, Byrne PJ, Murray ML, Carter P, Wong IC.

Drug Saf. 2009;32(4):325-33. doi: 10.2165/00002018-200932040-00006.

PMID:
19388723
4.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
5.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
6.

Antipsychotic polypharmacy or monotherapy?

Gardos G.

Neuropsychopharmacol Hung. 2005 Jun;7(2):72-7. Review.

PMID:
16167458
7.

Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness.

Lochmann van Bennekom MW, Gijsman HJ, Zitman FG.

J Psychopharmacol. 2013 Apr;27(4):327-36. doi: 10.1177/0269881113477709. Epub 2013 Feb 14. Review.

PMID:
23413275
9.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
10.

Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Haddad PM, Sharma SG.

CNS Drugs. 2007;21(11):911-36. Review.

PMID:
17927296
11.

Prolactin-related and metabolic adverse effects of atypical antipsychotic agents.

Henderson DC, Doraiswamy PM.

J Clin Psychiatry. 2008;69 Suppl 1:32-44. Review.

12.

Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics.

Gao K, Kemp DE, Fein E, Wang Z, Fang Y, Ganocy SJ, Calabrese JR.

J Clin Psychiatry. 2011 Aug;72(8):1063-71. doi: 10.4088/JCP.09r05535gre. Epub 2010 Oct 19.

13.

The efficacy, safety, and tolerability of antipsychotics in the elderly.

Maixner SM, Mellow AM, Tandon R.

J Clin Psychiatry. 1999;60 Suppl 8:29-41. Review.

14.

Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome.

Shirzadi AA, Ghaemi SN.

Harv Rev Psychiatry. 2006 May-Jun;14(3):152-64. Review.

PMID:
16787887
15.

Some adverse effects of antipsychotics: prevention and treatment.

Lader M.

J Clin Psychiatry. 1999;60 Suppl 12:18-21. Review.

16.

A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.

Kerwin R, Millet B, Herman E, Banki CM, Lublin H, Pans M, Hanssens L, L'Italien G, McQuade RD, Beuzen JN.

Eur Psychiatry. 2007 Oct;22(7):433-43. Epub 2007 Jun 7.

PMID:
17555947
17.

Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.

Tranulis C, Skalli L, Lalonde P, Nicole L, Stip E.

Drug Saf. 2008;31(1):7-20. Review.

PMID:
18095743
18.

Balancing efficacy and safety in treatment with antipsychotics.

Correll CU.

CNS Spectr. 2007 Oct;12(10 Suppl 17):12-20, 35. Review.

PMID:
17934385
19.

Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment.

Toteja N, Gallego JA, Saito E, Gerhard T, Winterstein A, Olfson M, Correll CU.

Int J Neuropsychopharmacol. 2014 Jul;17(7):1095-105. doi: 10.1017/S1461145712001320. Epub 2013 May 14. Review.

20.

Aripiprazole in schizophrenia and schizoaffective disorder: A review.

Stip E, Tourjman V.

Clin Ther. 2010;32 Suppl 1:S3-20. doi: 10.1016/j.clinthera.2010.01.021. Review.

PMID:
20152550
Items per page

Supplemental Content

Write to the Help Desk